Save the date for a one-day symposium on cannabinoid hyperemesis syndrome

Join UW’s Addictions, Drug & Alcohol Institute on Sept.18, for The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream, a free one-day symposium on cannabinoid hyperemesis syndrome.  

Cannabinoid hyperemesis syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment and patient communication without clear guidance.  

In a recent survey completed by UW ADAI, 70% of Washington health care providers reported treating patients experiencing severe abdominal pain, persistent nausea, retching and relentless vomiting associated with heavy cannabis use. 

Patients may not recognize cannabis as the cause of their symptoms, or may be skeptical that CHS exists at all, making effective care even more challenging. 

The learning event will share what is known regarding prevalence data, recommendations for diagnosis and treatment and clinical strategies to increase CHS awareness. Abstracts for posters can be submitted until Aug. 18, and a complete agenda can be found on the event website. (Brittany Weiner)